BioMarin to Attend Upcoming Investor Conferences

SAN RAFAEL, Calif., Aug. 15, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in Citi's Annual Biotech Conference on September 6, 2017 in Boston, Baird's 2017 Global Healthcare Conference on September 7, 2017 in New York and the Morgan Stanley 15^th Annual Global Healthcare Conference on September 12, 2017 in New York.  For information about webcasting, please visit the investor section of the BioMarin website, www.biomarin.com. A replay of all webcasts will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
[phone]	[phone]

 

View original content with multimedia:http://www.prnewswire.com/news-releases/biomarin-to-attend-upcoming-investor-conferences-300504281.html

SOURCE BioMarin Pharmaceutical Inc.

Copyright 2017 PR Newswire